Bioventus Corp (BVS) Operating Margin

Public company logo of Bioventus (BVS)

Stabilized management following the leadership transition and the automation of sterile lines at Bioventus Inc. (BVS) create a solid foundation for growth. Bioventus Inc. (BVS) minimizes risks through diversification across the bone repair and joint therapy segments. The shift in operating margin confirms the effectiveness of this strategy, and the value of 10.10 reflects the most recent figure for this key core business profitability metric.

Bioventus Inc (BVS): Operating Profitability from 07/04/2022 to 11/19/2026

Metric breakdowns and analytics for bioventus.com (BVS)

- share price and consensus valuation forecast:
Analysis of all company metrics:Bioventus Inc
Finished products of Bioventus Inc.

Bioventus Inc. occupies a significant niche in the high-tech orthopedic and trauma solutions sector. Analyzing operating margins allows investors to see the efficiency of the company's bone regeneration and joint therapy products. This metric is calculated as the ratio of operating profit to revenue, excluding the impact of taxes and debt service. It measures the business's ability to generate cash flow from its core operations. Steady growth in this indicator confirms the resilience of the business model and the fundamental attractiveness of the asset.

Main competitors

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|GMED: Operating Profitability|TMDX (TransMedics Corp) - Operating Sales Margin|Alphatec Holdings, Inc. - Operating Profit Rate|AORT (Artivion Corp) - Operating Margin|Operating Return on Sales Enovis Corp ENOV|Operating Profitability Integra LifeSciences Corp (IART)|Establishment Labs (ESTA) - Operating Profitability Margin|iLet Bionic Pancreas - Operating Sales Margin|Operating Margin IRADIMED CORPORATION IRMD|Embecta Corp - Operating Margin|Profitability of Operations Tandem Diabetes Care Inc TNDM|Axogen (AXGN) - Operating Profitability|Operating Profit Margin SIBN (SI-BONE Medical)|Operating Profitability orthofix.com|Operating Sales Margin OrthoPediatrics Corp. (KIDS)|Operating Margin TMCI|SRTA - Operating Return on Sales|Operating Profitability Carlsmed Inc CARL|RXST: Return on Sales by Operating Profit|CLPT: Operating Sales Margin|stereotaxis.com - Operating Profit Ratio|NeuroStar (STIM) - Operating Profitability|SGHT - Profitability of Operations|Operating Profitability Orchestra BioMed|Return on Sales by Operating Profit ANIK (Anika Therapeutics)|Operating Profitability inspiremd.com (NSPR)|Jin Medical International Ltd - Return on Sales by Operating Profit|Operating Margin VANI (Vivani Medical Inc)|XTNT: Return on Sales by Operating Profit|NMTC - Operating Profitability|MODD: Operating Profitability|MYO: Operating Margin|envoymedical.com - Operating Profit Rate|Operating Sales Margin VVOS|Operating Return on Sales enVVeno NVNO|Operating Margin SINT|TNON - Operating Return on Sales|Operating Profitability ReWalk Robotics LFWD|AMIX: Return on Sales by Operating Profit|IVF - Operating Profitability|Operating Return on Sales Bone Biologics Corp|AXNX: Operating Margin|Operating Sales Margin BIOLASE, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)